/Investor DB

Latin Leap — 2025 Investments

4 investments dated 2025 · listed companies and verified rows first · show all

Daptadapta.aiinMay 2025

Dapta is a no-code platform for building AI voice and text agents that handle calls, texts, lead qualification, appointment booking, and CRM updates.

AI & Machine LearningDeveloper ToolsSaaSSales TechDover, US

Juan Pablo GarridoinNicolas Rojas(Executive Officer, Director)in

PartnerStefan Krautwald· solo GP

Co-investors500 GlobalBroom VenturesInvariantes FundNuMundo VenturesFen Ventures

hevaheva.coinMar 2025

Heva operates an AI-powered medical tourism platform that matches patients with verified healthcare providers abroad, covering fields such as dental, cosmetic surgery, orthopedics, cardiac care, ophthalmology, and bariatric procedures.

AI & Machine LearningDigital HealthHealthtechMarketplacesNew York City, US

Varun Annadi(Executive Officer, Director)inHector Terrero(Director)

Co-investorsBenchstrength PartnersSpice CapitalTechstarsThe MBA FundAlpha PartnersCollide Capital+1 more

Mutuusps-mutuus.comin𝕏Mar 2025

Provides membership health plans in Mexico that include in-app access to nutritionists, psychologists, and general practitioners, 24/7 emergency telemedicine, ground ambulance service, discounted specialist consultations, and coverage for accidental death and funeral expenses.

Digital HealthHealthtechInsurTech

Jean-Louis Brunet Torres(Founder)in

Co-investorsAmador HoldingsDOMO.VCTantaucoAmadorG2 Momentum CapitalPreface Ventures

Zuzuzuzuhospitality.comSep 2025

ZUZU Hospitality provides property management software and revenue management tools for independent hotels, combining automated pricing, distribution across OTAs, and reservation management with human expertise.

PropTechSaaSTravel & HospitalitySingapore, SG

PartnerStefan Krautwald· solo GP

Co-investorsAC VenturesGolden Gate VenturesNSG VenturesTNBAuraVulpes VenturesWavemaker Partners+2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.